Hirudyne Vision Systems - See More. See Better.

Welcome to Hirudyne Vision Systems, a proud subsidiary of Vance Pharmaceuticals. We believe that human potential should not be limited by natural and biological evolution. Our groundbreaking research into symbiotic augmentation can help give you the ultimate edge in security, exploration, and high-stakes encounters.

The Hirudo Heliolens is a state-of-the-art vision-enhancement implant that merges seamlessly within your existing neural framework. By gently interfacing with your optic nerve, our premium vision enhancement upgrade unlocks unprecedented sensory capabilities without the need for traditional clunky external hardware cybernetics.

Key Advantages

Full-Spectrum Thermal Vision -

Gain thermal vision natively within the upgraded eye. Easily track heat signatures through common materials, giving you unmatched awareness in low-visibility or high-concealment situations. 

 Rapid Neural Integration -

Cybernetics can cause users distress and instability during the adjustment period. But not our product! Our advanced procedures ensure immediate usability, and full integration within 72 hours. Immediate post-operation care is included with every surgery to ensure you are feeling your best before you leave our clinic! 

 Ongoing Support - 

Long-term implant health is maintained through our proprietary formula, OptiFine. Regular adherence to this affordable medication ensures stability and peak performance.

 Financial Accessibility - 

Premium vision shouldn’t be out of reach. Our initial procedure costs start at just 10,000cr, with flexible payment options available. Speak with our clinic representatives today to find a plan that fits your budget. Hyrudine Vision Systems. See More. See Better. 

 Important Patient Disclosure & Terms of Agreement 

 OptiFine is a proprietary formula developed by Hirudyne Vision Systems (a subsidiary of Vance Pharmaceuticals). Continued, uninterrupted adherence to recommended dosage is required for implant stability. Failure to maintain adequate dosage may result in side effects including headaches, nausea, acute stress, migraines, glial cell degradation, local biological oviposition, permanent irreversible vision loss, and death. Hirudyne Vision Systems (a subsidiary of Vance Pharmaceuticals) is not responsible for any side effects as a result of failure to maintain an adequate medication regimen. Patient accounts in arrears are subject to Hirudyne asset recovery procedures as outlined in section 14, sub-section 22 of the standard Patient Agreement. All clinical data, biological byproducts, and harvested tissues remain the sole property of Hirudyne Vision Systems (a subsidiary of Vance Pharmaceuticals).